ICD-10 Specific code P35.1: Congenital cytomegalovirus infection
Specific codes in ICD-10 are unique alphanumeric designations used to identify and categorize diseases, disorders, and conditions. They consist of 3-5 characters, including both letters and numbers, that provide a high level of detail and specificity.
Translations
| Language | Translation |
|---|---|
English
|
Congenital cytomegalovirus infection |
French
|
Infection congénitale à cytomégalovirus |
Hierarchical position
| Level | Code | Title | |
|---|---|---|---|
| 1 | XVI | Certain conditions originating in the perinatal period | |
| 2 | P35-P39 | Infections specific to the perinatal period | |
| 3 | P35 | Congenital viral diseases | |
| 4 | P35.1 | Congenital cytomegalovirus infection |
Indicated medicines
| Active Ingredient |
|---|
|
Minocycline is a semi-synthetic derivative of tetracycline. Minocycline inhibits protein synthesis in susceptible bacteria. In common with other tetracyclines it is primarily bacteriostatic and has a similar spectrum of activity to other tetracyclines. |
|
Valaciclovir, an antiviral, is the L-valine ester of aciclovir. Valaciclovir is rapidly and almost completely converted in man to aciclovir and valine. Aciclovir is a specific inhibitor of the herpes viruses with in vitro activity against herpes simplex viruses (HSV) type 1 and type 2, varicella zoster virus (VZV), cytomegalovirus (CMV), Epstein-Barr Virus (EBV), and human herpes virus 6 (HHV-6). |